Fig. 4
From: TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer
Analysis of TEAD4 expression and its clinical correlation in BLCA tissues from TCGA database (A) Relative mRNA expression of TEAD4 in the TCGA-BLCA database. (B) Relative mRNA expression of TEAD4 in TCGA-BLCA + GTEx database. (C) Relative mRNA expression of TEAD4 in BLCA tissues and their paired normal tissues from the TCGA database. (D) TEAD4 mRNA expression level in different pT stage of BLCA samples from TCGA. (E) TEAD4 mRNA expression level in different tumor stage of BLCA samples from TCGA. (F) TEAD4 mRNA expression level in different tumor grade of BLCA samples from TCGA. Data are expressed as mean ± SD (*p < 0.05; **p < 0.01; ***p < 0.001). (G) Kaplan-Meier survival curves of BLCA patients with high and low expression of TEAD4